Effects of Vitrectomy on Recurrent Macular Edema due to Branch Retinal Vein Occlusion after Intravitreal Injection of Bevacizumab

Purpose. To evaluate the effects of pars plana vitrectomy (PPV) on recurrent macular edema due to branch retinal vein occlusion (BRVO) after intravitreal injections of bevacizumab (IVB). Methods. This retrospective study included 22 eyes of 22 patients who underwent single or multiple IVB injections...

Full description

Saved in:
Bibliographic Details
Main Authors: Tatsuya Yunoki, Keiichi Mitarai, Shuichiro Yanagisawa, Tsuyoshi Kato, Nobuo Ishida, Atsushi Hayashi
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2013/415974
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832567981022904320
author Tatsuya Yunoki
Keiichi Mitarai
Shuichiro Yanagisawa
Tsuyoshi Kato
Nobuo Ishida
Atsushi Hayashi
author_facet Tatsuya Yunoki
Keiichi Mitarai
Shuichiro Yanagisawa
Tsuyoshi Kato
Nobuo Ishida
Atsushi Hayashi
author_sort Tatsuya Yunoki
collection DOAJ
description Purpose. To evaluate the effects of pars plana vitrectomy (PPV) on recurrent macular edema due to branch retinal vein occlusion (BRVO) after intravitreal injections of bevacizumab (IVB). Methods. This retrospective study included 22 eyes of 22 patients who underwent single or multiple IVB injections for macular edema due to BRVO and showed a recurrence of macular edema. All patients then underwent PPV and were followed up for more than 6 months after the surgery with examinations of best corrected visual acuity (BCVA) and optical coherence tomography (OCT). OCT parameters were central macular thickness (CMT) and average retinal thickness in a 1-mm-diameter circular region at the fovea (MRT). Results. Mean BCVA, CRT, and MRT were significantly improved from the baseline after PPV. Greater improvement of BCVA, CRT, and MRT was obtained after 1 month of IVB than after 6 months of PPV. No eyes showed worsening of macular edema after the surgery. Conclusion. PPV improved BCVA and recurrent macular edema due to BRVO, but PPV that was less effective than IVB had been in the same patients. PPV may be one of the treatment options for recurrent macular edema due to BRVO after IVB.
format Article
id doaj-art-054ae0989b5047449a7d19632dbd5ca6
institution Kabale University
issn 2090-004X
2090-0058
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Journal of Ophthalmology
spelling doaj-art-054ae0989b5047449a7d19632dbd5ca62025-02-03T00:59:55ZengWileyJournal of Ophthalmology2090-004X2090-00582013-01-01201310.1155/2013/415974415974Effects of Vitrectomy on Recurrent Macular Edema due to Branch Retinal Vein Occlusion after Intravitreal Injection of BevacizumabTatsuya Yunoki0Keiichi Mitarai1Shuichiro Yanagisawa2Tsuyoshi Kato3Nobuo Ishida4Atsushi Hayashi5Department of Ophthalmology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0194, JapanDepartment of Ophthalmology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0194, JapanDepartment of Ophthalmology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0194, JapanDivision of Ophthalmology, Takaoka Municipal Hospital, 4-1 Takaramachi, Takaoka 933-8550, JapanIshida Eye Clinic, 2-2-31 Honcho, Jouetsu 943-0832, JapanDepartment of Ophthalmology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama 930-0194, JapanPurpose. To evaluate the effects of pars plana vitrectomy (PPV) on recurrent macular edema due to branch retinal vein occlusion (BRVO) after intravitreal injections of bevacizumab (IVB). Methods. This retrospective study included 22 eyes of 22 patients who underwent single or multiple IVB injections for macular edema due to BRVO and showed a recurrence of macular edema. All patients then underwent PPV and were followed up for more than 6 months after the surgery with examinations of best corrected visual acuity (BCVA) and optical coherence tomography (OCT). OCT parameters were central macular thickness (CMT) and average retinal thickness in a 1-mm-diameter circular region at the fovea (MRT). Results. Mean BCVA, CRT, and MRT were significantly improved from the baseline after PPV. Greater improvement of BCVA, CRT, and MRT was obtained after 1 month of IVB than after 6 months of PPV. No eyes showed worsening of macular edema after the surgery. Conclusion. PPV improved BCVA and recurrent macular edema due to BRVO, but PPV that was less effective than IVB had been in the same patients. PPV may be one of the treatment options for recurrent macular edema due to BRVO after IVB.http://dx.doi.org/10.1155/2013/415974
spellingShingle Tatsuya Yunoki
Keiichi Mitarai
Shuichiro Yanagisawa
Tsuyoshi Kato
Nobuo Ishida
Atsushi Hayashi
Effects of Vitrectomy on Recurrent Macular Edema due to Branch Retinal Vein Occlusion after Intravitreal Injection of Bevacizumab
Journal of Ophthalmology
title Effects of Vitrectomy on Recurrent Macular Edema due to Branch Retinal Vein Occlusion after Intravitreal Injection of Bevacizumab
title_full Effects of Vitrectomy on Recurrent Macular Edema due to Branch Retinal Vein Occlusion after Intravitreal Injection of Bevacizumab
title_fullStr Effects of Vitrectomy on Recurrent Macular Edema due to Branch Retinal Vein Occlusion after Intravitreal Injection of Bevacizumab
title_full_unstemmed Effects of Vitrectomy on Recurrent Macular Edema due to Branch Retinal Vein Occlusion after Intravitreal Injection of Bevacizumab
title_short Effects of Vitrectomy on Recurrent Macular Edema due to Branch Retinal Vein Occlusion after Intravitreal Injection of Bevacizumab
title_sort effects of vitrectomy on recurrent macular edema due to branch retinal vein occlusion after intravitreal injection of bevacizumab
url http://dx.doi.org/10.1155/2013/415974
work_keys_str_mv AT tatsuyayunoki effectsofvitrectomyonrecurrentmacularedemaduetobranchretinalveinocclusionafterintravitrealinjectionofbevacizumab
AT keiichimitarai effectsofvitrectomyonrecurrentmacularedemaduetobranchretinalveinocclusionafterintravitrealinjectionofbevacizumab
AT shuichiroyanagisawa effectsofvitrectomyonrecurrentmacularedemaduetobranchretinalveinocclusionafterintravitrealinjectionofbevacizumab
AT tsuyoshikato effectsofvitrectomyonrecurrentmacularedemaduetobranchretinalveinocclusionafterintravitrealinjectionofbevacizumab
AT nobuoishida effectsofvitrectomyonrecurrentmacularedemaduetobranchretinalveinocclusionafterintravitrealinjectionofbevacizumab
AT atsushihayashi effectsofvitrectomyonrecurrentmacularedemaduetobranchretinalveinocclusionafterintravitrealinjectionofbevacizumab